International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19
暂无分享,去创建一个
L. O’Driscoll | J. Lötvall | I. Reischl | A. Hill | M. Gimona | B. Levine | C. Théry | F. Borràs | J. Falcón-Pérez | S. Lim | R. Nieuwland | L. Ortiz | R. Sanzenbacher | B. Bussolati | M. Dominici | K. Witwer | W. Toh | E. Rohde | B. Giebel | M. Muraca | S. A. Mitsialis | D. Carter | D. D. de Kleijn | D. Phinney | D. Weiss | R. Lim | Johnathon D. Anderson | A. Hoffman | D. P. Kleijn | A. Nowocin | V. Börger | M. Monguió-Tortajada | W. S. Toh | J. Falcón‐Pérez | S. Mitsialis | Juan M. Falcon-Perez
[1] I. Colmegna,et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles , 2021, Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases.
[2] D. Hermann,et al. Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils , 2020, Stroke.
[3] I. Martin,et al. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential , 2020, Cytotherapy.
[4] David Berlin,et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.
[5] J. Cuenca,et al. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 , 2020, European Respiratory Journal.
[6] J. Hagood,et al. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease , 2020, International journal of molecular sciences.
[7] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[8] Lei Liu,et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome , 2020, medRxiv.
[9] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[10] M. Matthay,et al. Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome. , 2020, American journal of respiratory cell and molecular biology.
[11] Bo Diao,et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.
[12] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] A. Fernandez-Gonzalez,et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. , 2019, JCI insight.
[14] Jae W. Lee,et al. Mesenchymal Stem Cell–Derived Extracellular Vesicles Decrease Lung Injury in Mice , 2019, The Journal of Immunology.
[15] Q. Shu,et al. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury , 2019, Aging.
[16] Tu-feng Chen,et al. Exosomes Released by Bone Marrow Mesenchymal Stem Cells Attenuate Lung Injury Induced by Intestinal Ischemia Reperfusion via the TLR4/NF-κB Pathway , 2019, International journal of medical sciences.
[17] J. Lötvall,et al. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10 , 2019, Stem Cell Research & Therapy.
[18] C. Rathbone,et al. The effects of cell type and culture condition on the procoagulant activity of human mesenchymal stromal cell-derived extracellular vesicles. , 2019, The journal of trauma and acute care surgery.
[19] M. Gimona,et al. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. , 2019, Cytotherapy.
[20] J. Laffey,et al. Extracellular Vesicles from Interferon-&ggr;–primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli–induced Acute Lung Injury in Rats , 2019, Anesthesiology.
[21] A. Hill,et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications , 2019, Journal of extracellular vesicles.
[22] D. Hermann,et al. Identification of the right cell sources for the production of therapeutically active extracellular vesicles in ischemic stroke. , 2019, Annals of translational medicine.
[23] N. Y. Morozova,et al. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation , 2019, Cells.
[24] M. Exline,et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. , 2019, The Lancet. Respiratory medicine.
[25] S. Lim,et al. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. , 2018, Cytotherapy.
[26] T. Meulia,et al. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model , 2018, Stem Cell Research & Therapy.
[27] M. Ericsson,et al. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation , 2018, American journal of respiratory and critical care medicine.
[28] E. K. Cunningham,et al. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer , 2017, American journal of respiratory and critical care medicine.
[29] J. Laffey,et al. Fifty Years of Research in ARDS., Cell‐based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value , 2017, American journal of respiratory and critical care medicine.
[30] Bernd Giebel,et al. Concise Review: Developing Best‐Practice Models for the Therapeutic Use of Extracellular Vesicles , 2017, Stem cells translational medicine.
[31] Michel Bremer,et al. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents , 2017, International journal of molecular sciences.
[32] Mario Gimona,et al. Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use , 2017, International journal of molecular sciences.
[33] M. Gimona,et al. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. , 2017, Cytotherapy.
[34] Wael Nassar,et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases , 2016, Biomaterials Research.
[35] P. Horn,et al. Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cells , 2016, Cell cycle.
[36] D. Hermann,et al. Enabling Technologies for Cell-Based Clinical Translation Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression , 2015 .
[37] Qi Hao,et al. Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. , 2015, American journal of respiratory and critical care medicine.
[38] Andrew F. Hill,et al. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.
[39] S. Lim,et al. Mesenchymal stem cells secrete immunologically active exosomes. , 2014, Stem cells and development.
[40] M. Epple,et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease , 2014, Leukemia.
[41] M. Matthay,et al. Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin‐Induced Acute Lung Injury in Mice , 2014, Stem cells.
[42] Gerard Pasterkamp,et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. , 2013, Stem cell research.
[43] D. Phinney. Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.
[44] S. Lim,et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.
[45] L. Kanz,et al. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. , 2003, Haematologica.
[46] D J Prockop,et al. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.